Exogenous Glucagon-like Peptide 2 Counteracts Exogenous Cholecystokinin-induced Gallbladder Contraction in Healthy Men

J Clin Endocrinol Metab. 2024 Dec 18;110(1):123-129. doi: 10.1210/clinem/dgae421.

Abstract

Background and objective: Studies in humans and mice have demonstrated that the gut hormone glucagon-like peptide 2 (GLP-2) promotes gallbladder relaxation and refilling. Here, we assessed the effect of exogenous GLP-2 on gallbladder motility in the fasted state of healthy men with and without infusion of the potent gallbladder-contracting hormone cholecystokinin (CCK).

Methods: In a randomized, double-blind, placebo-controlled, crossover study, 15 male participants (mean [SD]: age 24.7 [3.6] years; body mass index 22.9 [1.6] kg/m2) underwent 4 experimental days receiving 2 infusions on each day: either CCK (0.4 pmol × kg-1 × min-1, time 0-180 minutes) + GLP-2 (10 pmol × kg-1 × min-1, time 30-240 minutes), CCK + placebo, placebo + GLP-2, or placebo + placebo, respectively. Gallbladder volume was measured at baseline and throughout the 4-hour study day using ultrasonography.

Results: Compared to placebo + placebo, GLP-2 + placebo did not affect gallbladder volume, but when infused in combination with CCK, GLP-2 completely abolished the strong gallbladder-contracting effect seen during CCK + placebo infusion, restoring baseline levels of gallbladder volume.

Conclusion: Exogenous GLP-2 counteracts exogenous CCK-induced gallbladder emptying in healthy men, pointing to a possible therapeutic potential for GLP-2 as a relaxing modulator of gallbladder smooth muscle tone (eg, as a bridge to surgery in biliary colic). The effect may also explain the gallbladder-related adverse events reported for GLP-2 receptor agonists used in the treatment of short bowel syndrome.

Clinical trial registration number: NCT04651868.

Keywords: CCK; GLP-1; GLP-2; gallbladder.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Cholecystokinin* / administration & dosage
  • Cholecystokinin* / pharmacology
  • Cross-Over Studies*
  • Double-Blind Method
  • Gallbladder Emptying* / drug effects
  • Gallbladder Emptying* / physiology
  • Gallbladder* / diagnostic imaging
  • Gallbladder* / drug effects
  • Gallbladder* / physiology
  • Glucagon-Like Peptide 2* / administration & dosage
  • Glucagon-Like Peptide 2* / pharmacology
  • Healthy Volunteers*
  • Humans
  • Male
  • Muscle Contraction* / drug effects
  • Young Adult

Substances

  • Glucagon-Like Peptide 2
  • Cholecystokinin

Associated data

  • ClinicalTrials.gov/NCT04651868